Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Access to medicines for rare diseases: A European regulatory roadmap for academia.
Rosenberg N, van den Berg S, Stolwijk NN, Jacobs BAW, Post HC, Pasmooij AMG, de Visser SJ, Hollak CEM. Rosenberg N, et al. Among authors: de visser sj. Front Pharmacol. 2023 Feb 28;14:1142351. doi: 10.3389/fphar.2023.1142351. eCollection 2023. Front Pharmacol. 2023. PMID: 36925633 Free PMC article.
Author Reply.
van den Berg S, de Visser SJ, Timmers L, Hollak CEM. van den Berg S, et al. Among authors: de visser sj. Value Health. 2022 Jan;25(1):158-159. doi: 10.1016/j.jval.2021.08.005. Epub 2021 Sep 21. Value Health. 2022. PMID: 35031095 Free article. No abstract available.
Cost-Based Price Calculation of Mexiletine for Nondystrophic Myotonia.
van den Berg S, van der Wel V, de Visser SJ, Stunnenberg BC, Timmers L, van der Ree MH, Postema PG, Hollak CEM. van den Berg S, et al. Among authors: de visser sj. Value Health. 2021 Jul;24(7):925-929. doi: 10.1016/j.jval.2021.02.004. Epub 2021 Apr 10. Value Health. 2021. PMID: 34243835 Free article.
A novel sustained-release cysteamine bitartrate formulation for the treatment of cystinosis: Pharmacokinetics and safety in healthy male volunteers.
Berends CL, Pagan L, van Esdonk MJ, Klarenbeek NB, Bergmann KR, Moerland M, van der Wel V, de Visser SJ, Büller H, de Loos F, de Vries WS, Waals H, de Leede LGJ, Burggraaf J, Kamerling IMC. Berends CL, et al. Among authors: de visser sj. Pharmacol Res Perspect. 2021 Apr;9(2):e00739. doi: 10.1002/prp2.739. Pharmacol Res Perspect. 2021. PMID: 33764642 Free PMC article. Clinical Trial.
Registries for orphan drugs: generating evidence or marketing tools?
Hollak CEM, Sirrs S, van den Berg S, van der Wel V, Langeveld M, Dekker H, Lachmann R, de Visser SJ. Hollak CEM, et al. Among authors: de visser sj. Orphanet J Rare Dis. 2020 Sep 3;15(1):235. doi: 10.1186/s13023-020-01519-0. Orphanet J Rare Dis. 2020. PMID: 32883346 Free PMC article.
23 results